[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100540260":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":29,"responsibleParty":60,"collaborators":62,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":10,"eligibilityCriteria":71,"healthyVolunteers":67,"sex":72,"minAge":73,"maxAge":74,"enrollmentInfo":75,"targetDuration":10,"studyType":78,"phases":10,"briefSummary":79,"conditions":80,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Bioray Laboratories","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"BRL-101",null,"All patients who have received BRL-101",[13],"Other: Assessments",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","Assessments","Safety and efficacy assessments",[9],[21],{"name":22,"affiliation":5,"role":23},"Xiaochen Wang, PhD","STUDY_CHAIR",[25],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","021-64340008","xcwang@brlmed.com",[30,47],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army","RECRUITING","Nanning","Guangxi","530021","China","CN",{"type":39,"coordinates":40},"Point",[41,42],108.31667,22.81667,{"lat":42,"lon":41},[45],{"name":46,"role":26,"phone":10,"phoneExt":10,"email":10},"Xinhua Zhang, PhD",{"facility":48,"status":32,"city":49,"state":50,"zip":51,"country":36,"countryCode":37,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"Xiangya Hospital of Central South University","Changsha","Hunan","510510",{"type":39,"coordinates":53},[54,55],112.97087,28.19874,{"lat":55,"lon":54},[58],{"name":59,"role":26,"phone":10,"phoneExt":10,"email":10},"Bin Fu, PhD",{"type":61,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[63,64],{"name":31,"class":16},{"name":48,"class":16},"100540260","long-term-follow-up-study-of-bhc001-for-tdt-100540260",false,"NCT06314529","Long-term Follow-up Study of BHC001 for TDT","Long-term Follow-up Study of BHC001 in the Treatment of Transfusion-dependent β-thalassemia","Inclusion Criteria:\n\n1. Provision of written informed consent for this study by subjects, or as applicable, subject's parent(s)\u002Flegal guardian(s)\n2. Treated with BRL-101 for therapy of transfusion-dependent β-thalassemia.\n\nExclusion Criteria:\n\n\\- There are no exclusion criteria for this study","ALL","5 Years","35 Years",{"count":76,"type":77},6,"ESTIMATED","OBSERVATIONAL","Observe long-term safety risk and long-term efficacy after intravenous infusion of BHC001 in TDT subjects.",[81],"Thalassemia, Beta","2024-03-11",{"date":84,"type":85},"2024-03-18","ACTUAL",{"date":87,"type":85},"2022-12-14",{"date":89,"type":77},"2037-05-10",{"name":5,"class":6},2]